C. Crowley

690 total citations
6 papers, 483 citations indexed

About

C. Crowley is a scholar working on Immunology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, C. Crowley has authored 6 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Immunology, 3 papers in Hepatology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in C. Crowley's work include Hepatitis C virus research (3 papers), T-cell and Retrovirus Studies (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). C. Crowley is often cited by papers focused on Hepatitis C virus research (3 papers), T-cell and Retrovirus Studies (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). C. Crowley collaborates with scholars based in United States and Spain. C. Crowley's co-authors include Richard C. Yocum, Ángel G. Martín, Madeleine Duvic, Y. Kim, Gary S. Wood, Elise A. Olsen, Ann Martin, Steven D. Reich, Peter Heald and James L. Freddo and has published in prestigious journals such as Circulation, Journal of Hepatology and Journal of the American Academy of Dermatology.

In The Last Decade

C. Crowley

6 papers receiving 472 citations

Peers

Countries citing papers authored by C. Crowley

Since Specialization

Citations

This map shows the geographic impact of C. Crowley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Crowley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Crowley more than expected).

Fields of papers citing papers by C. Crowley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Crowley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Crowley. The network helps show where C. Crowley may publish in the future.

Co-authorship network of co-authors of C. Crowley

This figure shows the co-authorship network connecting the top 25 collaborators of C. Crowley. A scholar is included among the top collaborators of C. Crowley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Crowley. C. Crowley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Pharmacokinetics and Pharmacodynamics of Setrobuvir, an Orally Administered Hepatitis C Virus Non-Nucleoside Analogue Inhibitor 2014 ·Clinical Therapeutics ·(unknown), Mohamad H. Rahimy, C. Crowley, James R. Appleman, Patrick F. Smith, James L. Freddo	7
2	2009 SAFETY AND ANTIVIRAL ACTIVITY OF ANA598 IN COMBINATION WITH PEGYLATED INTERFERON α2A PLUS RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE-1 CHRONIC HCV PATIENTS 2010 ·Journal of Hepatology ·E. Läwitz, (unknown), Vinod K. Rustgi, Tarek Hassanein, Mohamad H. Rahimy, C. Crowley, James L. Freddo, (unknown), John G. McHutchison	34
3	1055 ANTIVIRAL ACTIVITY OF ANA598, A POTENT NON- NUCLEOSIDE POLYMERASE INHIBITOR, IN CHRONIC HEPATITIS C PATIENTS 2009 ·Journal of Hepatology ·Eric Lawitz, M. Rodríguez‐Torres, Michael DeMicco, Tran Nguyen, Eliot Godofsky, James R. Appleman, Mohamad H. Rahimy, C. Crowley, James L. Freddo	32
4	Abstract 680: KC706, an Oral p38 MAP Kinase Inhibitor, Increases HDL-C 2007 ·Circulation ·Stephen G. Miller, C. Crowley, Jan O. Lundström, Christopher J. Larson, (unknown), Bernard D. King	1
5	Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial 2003 ·Journal of the American Academy of Dermatology ·Peter Heald, (unknown), Ann Martin, C. Crowley, Richard C. Yocum, Steven D. Reich	94
6	Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. 2001 ·PubMed ·Madeleine Duvic, Ángel G. Martín, Y. Kim, Elise A. Olsen, Gary S. Wood, C. Crowley, Richard C. Yocum, (unknown)	315

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact